[{"indications": "Indications\u00a0see under Dose", "name": "ALENDRONIC ACID With colecalciferol", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.6 Drugs affecting bone metabolism", "6.6.2 Bisphosphonates and other drugs affecting bone metabolism", "Bisphosphonates", "ALENDRONIC ACID", "With colecalciferol"], "cautions": "Cautions\u00a0upper gastro-intestinal disorders (dysphagia, symptomatic\r\noesophageal disease, gastritis, duodenitis, or ulcers\u2014see also under\r\nContra-indications and Side-effects); history (within 1 year) of ulcers,\r\nactive gastro-intestinal bleeding, or surgery of the upper gastro-intestinal\r\ntract; correct disturbances of calcium\r\nand mineral metabolism (e.g. vitamin-D deficiency, hypocalcaemia)\r\nbefore starting and monitor serum-calcium concentration\r\nduring treatment; consider dental check-up before\r\ninitiating bisphosphonate (risk of osteonecrosis\r\nof the jaw, see Bisphosphonates: Osteonecrosis\r\nof the Jaw); exclude other causes of osteoporosis; atypical femoral fractures, see MHRA/CHM advice; interactions: Appendix 1 (bisphosphonates)", "side-effects": "Side-effects\u00a0oesophageal reactions (see below), abdominal pain\r\nand distension, dyspepsia, regurgitation, melaena, diarrhoea or constipation,\r\nflatulence, musculoskeletal pain, headache; rarely rash, pruritus, erythema, photosensitivity, uveitis, scleritis,\r\ntransient decrease in serum calcium and phosphate; nausea, vomiting,\r\ngastritis, peptic ulceration, hypersensitivity reactions (including\r\nurticaria and angioedema), atypical femoral fractures with long-term\r\nuse (see MHRA/CHM advice);\r\nmyalgia, malaise, and fever at initiation of treatment; very\r\nrarely severe skin reactions (including Stevens-Johnson syndrome),\r\nosteonecrosis of the jaw (see Bisphosphonates: Osteonecrosis\r\nof the Jaw)Oesophageal reactions\u00a0Severe oesophageal reactions\r\n(oesophagitis, oesophageal ulcers, oesophageal stricture and oesophageal\r\nerosions) have been reported; patients should be advised\r\nto stop taking the tablets and to seek medical attention if they develop\r\nsymptoms of oesophageal irritation such as dysphagia, new or worsening\r\nheartburn, pain on swallowing or retrosternal pain", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129541.htm", "doses": ["Treatment of postmenopausal osteoporosis, 10\u00a0mg daily or 70\u00a0mg once weekly", "Treatment of osteoporosis in men, 10\u00a0mg daily", "Prevention and treatment of corticosteroid-induced osteoporosis\r\nin postmenopausal women not receiving hormone replacement therapy,\r\n10\u00a0mg daily", "treatment of postmenopausal osteoporosis in women at risk\r\nof vitamin D deficiency, 1 tablet once weekly", "Name[Fosavance\u00ae (MSD) ] Tablets, alendronic acid (as sodium\r\nalendronate) 70\u00a0mg, colecalciferol 70\u00a0micrograms (2 800\u00a0units), net\r\nprice 4-tab pack = \u00a322.80. Counselling,  administrationDose\u00a0treatment of postmenopausal osteoporosis in women at risk\r\nof vitamin D deficiency, 1 tablet once weeklyCounselling\u00a0Tablets should be swallowed whole\r\nwith plenty of water while sitting or standing; to be taken on an\r\nempty stomach at least 30 minutes before breakfast (or another oral\r\nmedicine); patient should stand or sit upright for at least 30 minutes\r\nafter taking tablet"], "pregnancy": "Pregnancy\u00a0avoid"}, {"indications": "Indications\u00a0see under Dose", "name": "ALENDRONIC ACID", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.6 Drugs affecting bone metabolism", "6.6.2 Bisphosphonates and other drugs affecting bone metabolism", "Bisphosphonates", "ALENDRONIC ACID"], "cautions": "Cautions\u00a0upper gastro-intestinal disorders (dysphagia, symptomatic\r\noesophageal disease, gastritis, duodenitis, or ulcers\u2014see also under\r\nContra-indications and Side-effects); history (within 1 year) of ulcers,\r\nactive gastro-intestinal bleeding, or surgery of the upper gastro-intestinal\r\ntract; correct disturbances of calcium\r\nand mineral metabolism (e.g. vitamin-D deficiency, hypocalcaemia)\r\nbefore starting and monitor serum-calcium concentration\r\nduring treatment; consider dental check-up before\r\ninitiating bisphosphonate (risk of osteonecrosis\r\nof the jaw, see Bisphosphonates: Osteonecrosis\r\nof the Jaw); exclude other causes of osteoporosis; atypical femoral fractures, see MHRA/CHM advice; interactions: Appendix 1 (bisphosphonates)", "side-effects": "Side-effects\u00a0oesophageal reactions (see below), abdominal pain\r\nand distension, dyspepsia, regurgitation, melaena, diarrhoea or constipation,\r\nflatulence, musculoskeletal pain, headache; rarely rash, pruritus, erythema, photosensitivity, uveitis, scleritis,\r\ntransient decrease in serum calcium and phosphate; nausea, vomiting,\r\ngastritis, peptic ulceration, hypersensitivity reactions (including\r\nurticaria and angioedema), atypical femoral fractures with long-term\r\nuse (see MHRA/CHM advice);\r\nmyalgia, malaise, and fever at initiation of treatment; very\r\nrarely severe skin reactions (including Stevens-Johnson syndrome),\r\nosteonecrosis of the jaw (see Bisphosphonates: Osteonecrosis\r\nof the Jaw)Oesophageal reactions\u00a0Severe oesophageal reactions\r\n(oesophagitis, oesophageal ulcers, oesophageal stricture and oesophageal\r\nerosions) have been reported; patients should be advised\r\nto stop taking the tablets and to seek medical attention if they develop\r\nsymptoms of oesophageal irritation such as dysphagia, new or worsening\r\nheartburn, pain on swallowing or retrosternal pain", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129540.htm", "doses": ["Treatment of postmenopausal osteoporosis, 10\u00a0mg daily or 70\u00a0mg once weekly", "Treatment of osteoporosis in men, 10\u00a0mg daily", "Prevention and treatment of corticosteroid-induced osteoporosis\r\nin postmenopausal women not receiving hormone replacement therapy,\r\n10\u00a0mg daily", "Tablets should be swallowed whole\r\nwith plenty of water while sitting or standing; to be taken on an\r\nempty stomach at least 30 minutes before breakfast (or another oral\r\nmedicine); patient should stand or sit upright for at least 30 minutes\r\nafter taking tablet"], "pregnancy": "Pregnancy\u00a0avoid"}]